Source: Annual Congress 2004 - Pathophysiology of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Marcos, E. Fadel, O. Sanchez, M. Humbert, P. Dartevelle, G. Simonneau, S. Adnot, S. Eddahibi (Creteil, Clamart, Le Plessis Robinson, France). Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Eur Respir J 2004; 24: Suppl. 48, 2695

Member's Comments

No comment yet.

Related content which might interest you: Role of endothelial and smooth muscle cells in vascular wall remodeling of large pulmonary arteries in patients with CTEPH Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007 Increased p130Cas activity induces smooth muscle cell proliferation and migration in idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 CCR2/CCR5-mediated macrophage–smooth muscle cell crosstalk in pulmonary hypertension Source: Eur Respir J, 54 (4) 1802308; 10.1183/13993003.02308-2018 Year: 2019 Hyperplasia of pulmonary artery smooth muscle cells in primary and secondary pulmonary hypertension is causally related to serotonin transporter overexpression Source: Eur Respir J 2002; 20: Suppl. 38, 5s Year: 2002 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats Source: Eur Respir J 2011; 37: 1104-1118 Year: 2011 Dexamethasone induces anti-remodelling effects in rat pulmonary arterial smooth muscle cells Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Vascular remodeling in chronic thromboembolic pulmonary hypertension: Involvement of dedifferentiated smooth muscle cells and C-reactive protein Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension Source: Eur Respir J 2007; 29: 937-943 Year: 2007 Contribution of angiopoietin/Tie2 pathway to pulmonary artery smooth muscle hyperplasia in idiopathic pulmonary hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Involvement of pulmonary artery smooth muscle cell apoptosis in simvastatin-induced regression of hypoxic pulmonary hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: possible mechanisms Source: Eur Respir J 2004; 24: Suppl. 48, 561s Year: 2004 miR-424 and muscle wasting in pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Caspase-1 triggers smooth muscle cell proliferation in hypoxic pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Shroom expression is attenuated in pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 871-880 Year: 2008 Increased expression of endothelinB receptors in the pulmonary arterial smooth muscle cells of fawn-hooded rat Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001 Pathophysiology of bronchial smooth muscle remodelling in asthma Source: Eur Respir J 2010; 36: 1174-1184 Year: 2010 Vascular smooth muscle cell phenotypes in primary pulmonary hypertension Source: Eur Respir J 2001; 17: 316-320 Year: 2001 Mir-17 modulates smooth muscle cell markers, apoptosis and BMPR-II levels in human pulmonary artery smooth muscle cells Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012